BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Tuesday, February 17, 2026
Home
»
Newsletters
» BioWorld
BioWorld
Sep. 13, 2010
View Archived Issues
Buyers' or Sellers' Market? Depends on Your Options
Read More
Alzheimer's NewCos Defend Gamma Secretase Targeting
Read More
Money Raised By Biotech in 2010
Read More
Week in Review
Read More
Word on the Street
Read More
Week in Washington
Read More
Next Wave of Japanese Deal-Making: Different than Last
Japanese pharmaceutical companies are taking a broad interest in U.S. and European biotechs, but both deal-making tactics and deal structures have evolved since the last headline-grabbing go-round in 2008.
Read More
Money Raised Year to Date
Read More
FDA Approvals in August
Read More
Phase I Clinical Trials Update: August 2010
Read More
Phase II Clinical Trials Update: August 2010
Read More
Phase III Clinical Trials Update: August 2010
Read More
Non-U.S. Clinical Trials & Regulatory Actions: August 2010
Read More
FDA Submissions, Approvals & Other Actions: August 2010
Read More
Stock Gainers and Losers For The Week
Read More
BioWorld Stock Report For Public Biotechnology Companies
Read More
